Skip to main content
. 2021 Jan 22;18(3):980. doi: 10.3390/ijerph18030980

Table 1.

NO and steroidogenesis.

Authors Animal Model NO Donors Used NOS Inhibitors Used Effects
Dave et al., 1997 [10] Rat In-vitro granulosa/lutein cells culture -SNP: 10−3 mol/L, 10−4 mol/L
-SNAP: 10−3 mol/L, 10−4 mol/L
-Progesterone synthesis inhibition in the presence of the nitric oxide donors in a concentration-dependent manner.
Ahsan et al., 1997 [14] Rat In-vitro culture of dispersed ovarian cells -SNP: 10−4 M and 10−3 M -Progesterone synthesis in cultures of ovarian dispersates dose dependently inhibited by SNP and inversely related to the concentrations of nitrites measured in the culture medium.
-Progesterone production stimulated by PGE2 (5 mM).
Mitsube et al., 1999 [15] Rat Ex-vivo perfused pre-ovulatory ovary -Spermine NONOate: 10 µmol/L and 100 µmol/L -L-NMMA: 300 µmol/L
-AG: 300 µmol/L and 1 mmol/L
-Steroid concentration in the perfusion media not affected by the NO inhibitors.
-NONOate (100 µmol/L) increased progesterone production.
Dong et al., 1999 [16] Rat In-vitro cultured ovaries -DETA/NO: 10–6, 10–5, 10–4 M
-DETA: 10–4M
-L-NAME: 10–4 M -Dose-dependent increase in progesterone synthesis, with a concomitant decrease in ovarian oestradiol secretion caused by DETA/NO.
-No effects on progesterone and oestradiol secretion by L-NAME (10−4 M).
Masuda et al., 2001 [17] Porcine In-vitro granulosa cells derived from small-sized (<3 mm) and medium-sized (3–5 mm) ovarian follicles -NOC18: 0.01–1.0 mmol/L -LNMMA: 0.01–1.0 mmol/L -NOC18 suppressed the basal and gonadotropin-stimulated E2 and inhibited progesterone release from small-sized follicles.
-No significant effect on progesterone release from medium-sized follicles by NOC18.
-Significant release of E2 and progesterone from both small-sized and medium-sized follicles in the presence of gonadotropin by LNMMA.
Van-Voorhis et al., 1994 [13] Human In-vitro granulosa-luteal cell -SNAP
-S-nitroso glutathione
-LNMMA
-N-nitro-arginase methyl ester.
-Inhibitors of NO synthase significantly increased estradiol secretion by granulosa-luteal cells.
-NO donors caused a dose-dependent decrease in both estradiol and progesterone secretion.
Kagabu et al., 1999 [18] Human In-vitro ovarian granulosa-luteal cells -SNAP: 10−5 M, 10−4 M, 10−3 M
-NOC12: 10−4 M, 10−3M
-Aromatase activity significantly inhibited by treatment with SNAP (10−4 M, 10−3 M) and NOC12 (10−4 M, 10−3 M) in a dose-dependent manner.
-Treatment with SNAP at 10−3 M decreased relative aromatase mRNA values and intracellular cyclic AMP concentrations.

AG—Aminoguanidine bicarbonate; DETA/NO—Diethylenetriamine/nitric oxide; DETA—Diethylenetriamine; L-NAME—NG-nitro-l-arginine methyl ester; L-NMMA—N(G)-monomethyl-L-arginine; NO—Nitric oxide; NOC12—ethanamine 1,1-diethyl-2-hydroxy-2-nitrosohydrazine; NOC18—1-Hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-trazene; NOS—Nitric oxide synthase; SNAP—S-nitroso-N-acetyl-penicillamine; SNP—Sodium nitroprusside; PGE2—Prostaglandin E2.